US drug approvals quicker but fewer in 2005-07
This article was originally published in SRA
Executive Summary
The time taken to steer a drug through clinical trials and Food and Drug Administration approval in the US dropped to an average of 7.2 years in 2005-07, the lowest level since the 7.1-year average recorded in 1999-2001. At the same time, though, the number of new chemical entities approved in the US dropped by 56% from a peak of 110 in 1996-98 to just 48 in 2005-07.